Neovagina: Creation, Function, and Recovery Process

A neovagina is a surgically or non-surgically created vaginal canal, constructed for transgender women undergoing gender-affirming vaginoplasty or for cisgender women born without a vagina due to conditions like Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. The procedure has evolved considerably over the past few decades, with several distinct techniques now available, each carrying its own trade-offs in tissue type, recovery demands, and long-term function. Satisfaction rates across methods are consistently high, but the path to full recovery is longer and more involved than many people expect.

Who Gets a Neovagina and Why

The two main populations seeking neovaginal creation are transgender women pursuing gender-affirming surgery and cisgender women with vaginal agenesis. In gender-affirming vaginoplasty, the procedure is part of a larger operation that also includes penectomy, orchiectomy, urethroplasty, and labiaplasty, which is why operative time often exceeds four hours compared with roughly two to three hours for vaginal reconstruction alone in cisgender patients undergoing similar canal-creation techniques.¹ The underlying goal in both groups is the same: to create a functional vaginal canal with adequate depth and width, lined with tissue that can heal and be maintained over the long term.

Surgical Techniques

There is no single “best” surgery for creating a neovagina. Surgeons choose among several well-established methods based on available tissue, patient anatomy, and clinical goals. The three most widely used approaches are penile inversion vaginoplasty, intestinal vaginoplasty, and peritoneal flap vaginoplasty.

Penile Inversion Vaginoplasty

Penile inversion is the most common technique in gender-affirming surgery. It uses penile and sometimes scrotal skin to line the newly created vaginal canal. The skin is inverted into a surgically dissected space between the bladder and rectum. Because the graft comes from the patient’s own genital tissue, no abdominal surgery is required, and the operation can typically be completed in a single stage. The trade-off is that vaginal depth depends on how much usable skin is available. Patients who were circumcised or who have limited penile tissue may end up with a shallower canal, which sometimes leads to a revision procedure later.

Intestinal Vaginoplasty

When skin graft material is insufficient or when a revision is needed for vaginal stenosis, surgeons may harvest a segment of intestine to line the canal. The sigmoid colon is the most commonly used section. Compared with the ileum (the other intestinal option sometimes used), the sigmoid produces less copious secretions and better matches the width of a vaginal canal without needing additional surgical reshaping.² A large review of intestinal vaginoplasty covering nearly 900 patients found that complication rates were generally low; the most common issue was narrowing at the vaginal opening, requiring surgical correction in about 4% of sigmoid-based procedures and roughly 1% of ileum-based ones.³ Because the procedure involves harvesting bowel, it carries the added complexity and recovery burden of abdominal surgery, including a brief period where normal bowel function is disrupted.

Peritoneal Flap Vaginoplasty

A newer option uses the peritoneum, the thin membrane that lines the abdominal cavity, to create the upper portion of the vaginal canal. This can be combined with a penile skin graft for the lower segment. A robotic-assisted version of the technique (the Davydov procedure) has shown that the peritoneal flap can add about five centimeters of depth beyond what a skin graft alone provides, resulting in total depths averaging around 14 cm.⁴ Laparoscopic approaches, including three-dimensional laparoscopic techniques using a rectosigmoid flap, have also been refined in recent years with promising safety profiles.⁵ Because peritoneal tissue is thin and pliable, it tends to adapt well, though it shares with intestinal tissue the trait of continuous baseline secretion rather than arousal-responsive lubrication.

Non-Surgical Creation Through Dilation

Not everyone who needs a neovagina requires surgery. For cisgender women with vaginal agenesis, progressive self-dilation using graduated dilators (the Frank method, or variations like the Ingram method that use a bicycle-seat apparatus) can create a functional vaginal canal over weeks to months. This approach has the advantage of low complication rates, no surgical scarring, and a vaginal lining that develops from the patient’s own tissue stretching and adapting over time.⁶ Many professional guidelines recommend dilation as the first-line treatment for vaginal agenesis before considering surgery.⁷ Dilator therapy also plays a critical role after surgical vaginoplasty of any kind, as discussed in the recovery section below, where it serves a different purpose: maintaining the canal that surgery has created rather than creating one from scratch.

Preparing for Surgery

Preparation for gender-affirming vaginoplasty begins months before the operating room. One of the most overlooked requirements is hair removal from the genital skin that will become the vaginal lining. Because penile and scrotal skin is hair-bearing, any follicles left behind can cause chronic infections, folliculitis, odor, and even hairball formation inside the neovaginal canal. Research strongly supports completing permanent hair removal before surgery to avoid these complications.⁸ Electrolysis and laser hair removal are both used; laser is faster over large areas, while electrolysis can target individual follicles regardless of hair or skin color.

Pelvic floor physical therapy before surgery is another preparation step gaining traction. A program at one surgical center found that 42% of patients assessed before vaginoplasty already had pelvic floor dysfunction and 37% had bowel dysfunction. Among patients who attended pelvic floor therapy both before and after surgery, the rate of postoperative pelvic floor problems was dramatically lower (28%) compared with those who only attended after surgery (86%).⁹ Knowing how to relax the pelvic floor muscles before surgery makes post-surgical dilation easier and less painful.

Recovery and Dilation

Recovery from vaginoplasty is not a matter of weeks. The immediate hospital stay is typically a few days, but the full recovery process stretches over many months and involves significant daily commitment. The single most important post-operative task is regular neovaginal dilation. Without it, the body treats the new canal as a wound and tries to close it through scar contraction. Most surgical centers prescribe dilation multiple times per day in the early weeks, gradually tapering in frequency over months and eventually years, though some degree of ongoing dilation or regular penetrative activity is generally needed indefinitely.

Dilation is often the most challenging part of recovery. It can be painful in the first weeks, is time-consuming, and requires privacy and planning. Patients commonly describe the early dilation schedule as the hardest aspect of the entire surgical experience. Pelvic floor physical therapy after surgery helps patients learn to relax the muscles around the neovaginal canal, making dilation more tolerable. Transgender women frequently deal with urinary incontinence, prolonged pelvic pain, and neovaginal stenosis in the post-operative period, all of which respond to physical therapy.¹⁰

Swelling, bruising, and limited mobility are expected in the first several weeks. Most patients can return to sedentary work in four to six weeks, though strenuous activity is restricted longer. Complete nerve healing, which affects sensation, continues for a year or more.

How the Tissue Adapts Over Time

What happens to transplanted skin inside the body is a question patients often have, and the answer depends on the tissue source. Penile skin used in inversion vaginoplasty does not appear to transform into mucosal tissue. A histological study of skin-lined neovaginas found no changes in the tissue structure attributable to the vaginal environment or hormone therapy, whether examined shortly after surgery or years later.¹¹ The skin remains skin, which is why it does not self-lubricate in a meaningful way.

In contrast, skin grafts placed during the McIndoe procedure (used primarily in cisgender women with vaginal agenesis) do show a gradual transformation. Biopsies at three months show thickening, at six months partial adaptation toward mucosa, and by twelve months full mucosal adaptation.¹² This discrepancy likely reflects differences in the hormonal environment, the specific tissue used, and the preparation of the graft. The takeaway for patients is that skin-lined neovaginas in transgender women typically function well but remain skin in character, with lubrication needing external supplementation.

Lubrication

Lubrication is one of the most common concerns patients raise, and the reality varies sharply by surgical technique. Penile and scrotal skin have no inherent lubricating ability. However, when the surgical technique incorporates urethral tissue or preserves periurethral glands, some sexually responsive secretory fluid can result. This is not vaginal lubrication in the traditional sense, but some patients find it provides partial moisture during arousal.¹³

Intestinal and peritoneal tissues both produce fluid, but this production is continuous and unrelated to arousal. For intestinal vaginoplasties in particular, the volume can be considerable. Some patients find the constant moisture manageable, while others consider it excessive enough to require daily panty liners. Neither technique produces the arousal-responsive lubrication of a natal vagina, so personal lubricant remains a practical necessity for most patients during sexual activity regardless of surgical method.

Sensation and Orgasm

Erogenous sensation after vaginoplasty depends heavily on surgical technique and the preservation of the dorsal nerve of the clitoris (formed from what was previously the dorsal nerve of the penis). The neoclitoris, fashioned from the glans during surgery, retains sensory nerve endings, and most patients report meaningful erogenous sensation once nerve healing is complete, which can take six months to over a year.

Across studies, orgasm rates after vaginoplasty cluster around 75% to 90%. A meta-analysis found that 76% of patients overall reported the ability to orgasm, with a higher rate of 95% among those who had intestinal vaginoplasty compared with 73% for penile skin inversion.¹⁴ A separate study of clitoral sensation found that 90% of transgender women reported orgasm within six months of surgery, with age and medical conditions influencing outcomes.¹⁵ Among patients who could orgasm before surgery, about 80% retained that ability afterward, and roughly 29% of those who had never orgasmed before surgery were able to do so for the first time.¹⁶ Orgasm after vaginoplasty is widely described by patients as feeling different from pre-surgical orgasm, often more diffuse, but the capacity is preserved in the clear majority of cases.

The Neovaginal Microbiome

The bacterial community inside a neovagina is distinct from that of a natal vagina and varies by surgical technique. In skin-lined neovaginas, the microbiome tends to resemble the pattern seen in bacterial vaginosis rather than a healthy natal vaginal microbiome dominated by Lactobacillus.¹⁷ An early culture-based study found an average of nearly nine species per patient, with common skin and gut organisms predominating. Lactobacillus was found in only one of thirty patients sampled.¹⁸

More recent genomic work has identified four distinct bacterial clusters in penile inversion neovaginas, each with a different immune signature. One cluster, dominated by anaerobic bacteria like Fastidiosipila and Ezakiella, was stable and associated with lower inflammation. Another cluster containing Fusobacterium and Parvimonas correlated with higher inflammatory markers. Although Lactobacillus was detected in some patients, true Lactobacillus dominance was rare.¹⁹ The clinical meaning of these findings is still being sorted out. Patients sometimes worry about unusual discharge or odor, and understanding that the neovaginal microbiome is fundamentally different from a natal vaginal microbiome can help both patients and clinicians avoid unnecessary antibiotic treatments aimed at restoring a Lactobacillus-dominated state that was never present to begin with.

Intestinal vaginoplasties develop a microbiome that resembles the colorectal environment, which makes sense given the tissue source.¹⁷ This different microbial profile is one reason the discharge characteristics differ so much between techniques.

Complications

Like any major surgery, vaginoplasty carries risks. The most common complication across all techniques is stenosis, or narrowing of the vaginal canal, which is why dilation adherence matters so much. When stenosis becomes severe enough to require a secondary procedure, surgeons may use either a peritoneal flap or an intestinal segment to re-establish depth. A comparison of these two revision approaches found that peritoneal flap revisions carried a higher rate of recurrent stenosis (about a third of cases) compared with intestinal revisions, though intestinal revisions came with their own issues, including mucosal prolapse in roughly 8% of patients.²⁰

Fistulas, or abnormal connections between the neovagina and adjacent structures like the rectum or urethra, are rarer but more serious. In a large series of over a thousand patients, about 2.3% developed a fistula. Patients undergoing revision surgery faced a substantially higher risk of rectoneovaginal fistula compared with those having a primary procedure. Most fistulas were managed with local surgical repair, though some required temporary fecal or urinary diversion.²¹ Rectal injury during the initial dissection is an inherent risk when creating the neovaginal space, given the tight anatomic quarters, but intraoperative detection and repair reduces the chance of it progressing to a fistula.²² Among fistula repair methods studied in a systematic review, recurrence was seen in about 15% of cases, with primary closure and reconstructive flap techniques both carrying some risk of the fistula returning.²³

Patient Satisfaction and Regret

Despite the long recovery and complication risks, patient satisfaction after vaginoplasty is high by surgical standards. A meta-analysis pooling data across studies reported overall satisfaction at 91%, with functional and aesthetic satisfaction at 87% and 90% respectively. For intestinal vaginoplasty specifically, overall satisfaction reached 99%, though functional and aesthetic satisfaction were similar to penile inversion outcomes. The overall regret rate was about 2%, and for intestinal vaginoplasty it was under 1%.¹⁴ A separate quality-of-life study found that 91% of patients reported improved quality of life, and all respondents said they would undergo the surgery again.²⁴

These numbers do come with a caveat: satisfaction studies in this field tend to have high loss to follow-up, and it is possible that dissatisfied patients are less likely to respond. Still, the consistency of the numbers across multiple studies and techniques is striking, and the very low regret rates suggest that for the vast majority of patients, the outcome aligns with their goals.

Tissue Engineering and What May Come Next

The frontier of neovaginal creation lies in tissue engineering, an approach that aims to grow vaginal tissue in a laboratory and implant it, potentially eliminating the need to harvest tissue from elsewhere in the body. Research has focused on seeding biodegradable scaffolds with a patient’s own cells. Work with vaginal epithelial cells and smooth muscle cells on porous polymer scaffolds has shown that cells retain their function and structure during laboratory culture, suggesting these materials could support tissue growth if implanted.²⁵ Scaffold strategies combined with mesenchymal stem cells are also being explored as a way to promote tissue repair and regeneration.²⁶

A systematic review of tissue engineering for vaginoplasty noted that autologous vaginal cells combined with natural extracellular matrix biomaterials showed the most promising properties, but emphasized that clinical trial confirmation is still needed. Achieving adequate blood supply to a full-sized engineered neovagina remains one of the biggest technical hurdles.²⁷ A small number of patients with MRKH syndrome have already received tissue-engineered vaginal constructs, but the technology is years away from routine clinical use, and its application to gender-affirming surgery introduces additional complexities. For now, the existing surgical and non-surgical methods remain the standard, and they continue to be refined incrementally with better tools, imaging, and perioperative care.